Comparative Study
Clinical significance of plasma lipid-bound sialic acid (LBSA) and carcinoembryonic antigen (CEA) in gynaecologic cancer patients
- PMID: 4029198
Item in Clipboard
Comparative Study
Clinical significance of plasma lipid-bound sialic acid (LBSA) and carcinoembryonic antigen (CEA) in gynaecologic cancer patients
Eur J Gynaecol Oncol.
1985.
Abstract
A comparison between plasma lipid-bound sialic acid (LBSA) and carcinoembryonic antigen (CEA) in gynaecologic cancer patients has been performed. The LBSA level appears more specific then the CEA, especially for ovarian cancer. This finding has promoted a longitudinal study to show if LBSA test may prove a reliable marker of disease in ovarian cancer patients.
Similar articles
-
[Monitoring the course of malignant neoplasms of the genital organs in women by means of determination of blood serum level of fucose, sialic acid, CEA and AFP].Ginekol Pol. 1979 Dec;50(12):1029-36. Ginekol Pol. 1979. PMID: 94024 Polish. No abstract available.
-
Detection of gastric cancer by a combination of tissue polypeptide antigen (TPA), lipid-bound sialic acid (LBSA) and carcinoembryonic antigen (CEA).Gastroenterol Jpn. 1984 Oct;19(5):424-9. doi: 10.1007/BF02807254. Gastroenterol Jpn. 1984. PMID: 6519414
-
Lipid bound sialic acid in cancer patients.Tumori. 1985 Apr 30;71(2):127-33. doi: 10.1177/030089168507100207. Tumori. 1985. PMID: 4002346
-
The utility of lipid-associated sialic acid (LASA or LSA) as a serum marker for malignancy. A review of the literature.Tumour Biol. 1992;13(3):121-32. doi: 10.1159/000217755. Tumour Biol. 1992. PMID: 1626178 Review.
-
The clinical significance of carcinoembryonic antigen in the plasma and tumors of patients with gynecologic malignancies.Cancer. 1978 Sep;42(3 Suppl):1527-32. doi: 10.1002/1097-0142(197809)42:3+<1527::aid-cncr2820420826>3.0.co;2-l. Cancer. 1978. PMID: 101294 Review.